相关实验视频

Updated: Jun 18, 2025

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

结合放射性免疫治疗方案可以在小鼠中根除晚期瘤

Alexander L Rakhmilevich¹, Noah W Tsarovsky¹, Mildred Felder¹

¹Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States.

Frontiers in immunology

|July 30, 2024

概括

这项研究表明,联合放射性免疫疗法 (CRI) 方案可以根除大型晚期小鼠瘤. 治疗有效地减少了调节性T细胞,导致显著的瘤回归和长期免疫记忆.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
辐射疗法辐射疗法

背景情况:

晚期癌症往往会抵抗标准免疫疗法.
大多数实验性癌症免疫疗法是在小瘤上进行测试的.

研究的目的:

为了确定联合放射免疫疗法 (CRI) 方案是否可以根除大型晚期小鼠瘤.
评估CRI对各种小鼠瘤模型的疗效.

主要方法:

CRI涉及局部放射治疗,内IL-12,全身IL-2和抗CTLA-4抗体.
对B78黑色素瘤,MC38,CT26结肠癌和9464D神经母细胞瘤的治疗效果进行了评估.
免疫细胞枯竭和流细胞计分析了治疗机制.

主要成果:

CRI根除了体积为2000毫米3或更大的瘤.
治疗减少了调节性T (Treg) 细胞,并增加了CD8/Treg比率.
对于对抗远程瘤的全身效应,T细胞至关重要,而局部瘤缩发生得很快.

结论:

合理设计的组合免疫疗法可以有效地对抗大型晚期瘤.
CRI诱导全身抗瘤免疫和免疫记忆.

关键词:

癌症免疫疗法免疫疗法组合 (组合) 疗法组合 (组合) 治疗在晚期的瘤中.鼠标瘤模型鼠标瘤模型放射性免疫疗法是一种放射性免疫疗法.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.